Acquisition History / Kotak Strategic Situations India Fund II / Tianish Laboratories Private Limited

Kotak Strategic Situations India Fund II Acquires Tianish Laboratories Private Limited

Announced January 2024 — Price not disclosed (CCI combination order)

Kotak Strategic Situations India Fund IIPharmaceuticals2024

What happened

API and pharmaceutical manufacturer Acquired through Kotak Strategic Situations India Fund II, a vehicle of Kotak Alternate Asset Managers Limited; Matrix Pharma Private Limited. Source: https://www.cci.gov.in/images/summaryorders/en/summary1713874557.pdf

Acquirer
Kotak Strategic Situations India Fund II
Target
Tianish Laboratories Private Limited
Announced
January 2024
Price
Price not disclosed (CCI combination order)
Industry
Pharmaceuticals
Buyer type
Private equity
Fund vehicle
Kotak Strategic Situations India Fund II
Backing investors
Kotak Alternate Asset Managers Limited, Matrix Pharma Private Limited
Status
Closed

By the numbers

Kotak Strategic Situations India Fund II's acquisition history
1st of 2 tracked deals
Disclosed prices
1 of 2 Kotak Strategic Situations India Fund II deals
Kotak Strategic Situations India Fund II's average disclosed price
$135.6M
Kotak Strategic Situations India Fund II's largest disclosed deal
Ace Designers Limited ($135.6M)
Tracked acquisitions in 2024
157 across all acquirers
Kotak Strategic Situations India Fund II in Pharmaceuticals
1 acquisition

Frequently Asked Questions About This Acquisition

When did Kotak Strategic Situations India Fund II acquire Tianish Laboratories Private Limited?

Kotak Strategic Situations India Fund II acquired Tianish Laboratories Private Limited on January 2024. This was Kotak Strategic Situations India Fund II's 1st publicly tracked acquisition out of 2 we have on record.

How much did Kotak Strategic Situations India Fund II pay for Tianish Laboratories Private Limited?

Kotak Strategic Situations India Fund II paid Price not disclosed (CCI combination order) for Tianish Laboratories Private Limited.

What does Tianish Laboratories Private Limited do?

API and pharmaceutical manufacturer Acquired through Kotak Strategic Situations India Fund II, a vehicle of Kotak Alternate Asset Managers Limited; Matrix Pharma Private Limited. Source: https://www.cci.gov.in/images/summaryorders/en/summary1713874557.pdf

What other Pharmaceuticals companies has Kotak Strategic Situations India Fund II acquired?

Tianish Laboratories Private Limited is Kotak Strategic Situations India Fund II's only publicly tracked acquisition in Pharmaceuticals so far.

Read the full article →

More Kotak Strategic Situations India Fund II acquisitions

See all 2 Kotak Strategic Situations India Fund II acquisitions →

More Pharmaceuticals acquisitions